
Dr. Kauf’s research interests include technology assessment and health services research in the areas of infectious disease and diseases affecting the elderly, including congestive heart failure and osteoarthritis. She is particularly interested in Medicare policy and physician adherence to clinical practice guidelines and patient adherence to medical care and prescription drug therapy as a function of patient risk factors such as age or disease severity.
Prior to joining UF, Dr. Kauf held appointments at the University of North Carolina School of Pharmacy and the Center for Clinical and Genetic Economics at Duke University. In addition to her academic research experience, Dr. Kauf worked with a variety of private and public institutions, including GlaxoSmithKline, the American Medical Association, California Medical Review Inc, and the California Department of Health Services. Dr. Kauf’s broad professional experience lends a unique perspective to her teaching and research.
Selected Publications:
Fischl MA, Burnside Jr AF, Farthing CF, et al. Twice-daily Trizivir versus Combivir/abacavir in antiretroviral-experienced adults with HIV-1 infection: A formulation-switch trial. Pharmacotherapy. Nov 2003; 23(11): 1432-1440.
Kauf TL, Shih YC. Use of home health care by ESRD and Medicare beneficiaries. Health Care Financ Rev. 1999 Summer;20(4):127-38.
Kauf TL. What is the government's perspective? Med Decis Making. 1999 Jan-Mar;19(1):98-9.
Kauf TL. Are state immunization programs effective? Implications for the children's immunization initiative. Clin Ther. 1998 Jul-Aug;20(4):806-19.